Business
Why has the Kazia Therapeutics (ASX:KZA) share price skyrocketed 80% in 1 month?
The Kazia Therapeutics Ltd (ASX: KZA) share price is one of the best performers on the ASX this past month, almost doubling in value before retreating today by 12% to $1.53. Overall, the drugmaker’s share price has gained over 82% during the past month of trading.
Why the big rise in the Kazia share price
Kazia is a Sydney-based, oncology-focused biotechnology drugmaker. The company’s flagship is the paxalisib drug used for the treatment of glioblastoma, which is the most common and aggressive form of primary brain cancer. The Kazia share price has risen strongly on the back of the ongoing and promising development of this particular drug.
In August, paxalisib was granted a fast track designation (FTD) by the United…
-
Noosa News12 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General22 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Business21 hours agoRevenue growth, profit margin pressures, and a $365m buyback
-
Noosa News23 hours agoUrgent recall notice issued for deli meats over contamination risk